Paul J. Schupf

Paul J. Schupf is an American epidemiologist and gerontologist noted for research on the epidemiology of Alzheimer disease, dementia, and aging-related cognitive decline. He has held academic appointments and contributed to large cohort studies linking genetic, environmental, and clinical factors to neurodegenerative outcomes. His work intersects with clinical neurology, public health, genetics, and geriatrics.

Early life and education

Schupf was born in the United States and trained in the postwar era that produced advances in epidemiology and public health institutions. He completed undergraduate work at an American university and received graduate training culminating in a doctorate relevant to population health and biomedical research, training alongside scholars associated with National Institutes of Health, Centers for Disease Control and Prevention, and academic centers such as Columbia University, Harvard University, and Johns Hopkins University. During his formative years he encountered faculty from institutions including Yale University, University of Pennsylvania, University of Michigan, Stanford University, and University of California, San Francisco.

Academic and research career

Schupf’s early appointments connected him to university medical centers and research programs in aging and neurology, collaborating with investigators at Columbia University Irving Medical Center, Mount Sinai Health System, Albert Einstein College of Medicine, New York University School of Medicine, and other Bronx and New York–area institutions. He participated in cohort studies and consortia that included linkage with Framingham Heart Study, Rotterdam Study, Cardiovascular Health Study, and multicenter networks tied to National Institute on Aging activities. His collaborations extended to researchers affiliated with National Institute of Neurological Disorders and Stroke, Centers for Medicare & Medicaid Services, Montefiore Medical Center, Weill Cornell Medicine, and international partners at King's College London, University College London, Karolinska Institutet, and McGill University. Schupf contributed to studies integrating biomarkers from magnetic resonance imaging, positron emission tomography, and molecular assays connected with laboratories at Broad Institute, Roche Diagnostics, Quest Diagnostics, and academic biobanks.

Major contributions and publications

Schupf’s publications addressed genetic risk factors such as the role of APOE alleles in cognitive decline, interactions with vascular factors described in studies that cited work from Framingham Heart Study investigators and reports published in journals associated with American Heart Association networks and Alzheimer's Association conferences. He authored and coauthored observational analyses on dementia incidence in cohorts like the Washington Heights-Inwood Columbia Aging Project and longitudinal research interfacing with datasets from Medicare claims and registries maintained by National Center for Health Statistics. His papers examined interactions among lipid metabolism genes, inflammatory markers studied by teams at Harvard School of Public Health and Johns Hopkins Bloomberg School of Public Health, and social determinants similar to those explored by investigators at Princeton University and University of Chicago. Schupf published findings in journals connected to editorial boards at The Lancet, Journal of the American Medical Association, Neurology (journal), Annals of Internal Medicine, and specialty venues associated with American Neurological Association proceedings. He contributed chapters or articles that cited methodologies used in genomic studies by the International Genomics Consortium and statistical approaches developed by groups at University of Cambridge and Massachusetts Institute of Technology.

Awards and honors

Over his career Schupf received recognition from institutions and organizations that include academic departments at Albert Einstein College of Medicine, research centers funded by National Institute on Aging, and honors conferred at meetings organized by the Alzheimer's Association, American Association for the Advancement of Science, and regional societies linked to American Geriatrics Society. He was invited to present at symposia hosted by National Institutes of Health and received awards or named lectureships related to contributions in dementia epidemiology, called out in programs by Columbia University, Mount Sinai, Weill Cornell Medicine, and affiliated medical centers.

Personal life and legacy

Schupf’s personal life included ties to academic communities in the New York area where he mentored trainees from institutions such as Columbia University Vagelos College of Physicians and Surgeons, Albert Einstein College of Medicine, Mount Sinai School of Medicine, and New York University Grossman School of Medicine. His legacy persists through mentees who joined faculties at Johns Hopkins University School of Medicine, Harvard Medical School, University of Pennsylvania Perelman School of Medicine, Stanford University School of Medicine, and through datasets used by investigators at Broad Institute and international collaborators at University College London and Karolinska Institutet. His contributions inform policy discussions in venues associated with Centers for Disease Control and Prevention and National Institute on Aging programs, and his publications continue to be cited in work by researchers at Massachusetts General Hospital, Brigham and Women's Hospital, UCLA Health, University of California, San Diego, and other centers studying aging and neurodegeneration.

Category:American epidemiologists Category:American gerontologists